Friday, September 16, 2016 | 8:30 AM - 6:00 PM
Speakers: Jason Block (Harvard University), Matthew Harding (Duke University), John Kral (SUNY Downstate Medical Center), Satchidananda Panda (SALK Institute), Michael Price (Georgia State University), Ruth E. Patterson (UC San Diego), Lori B. Andrews (Illinois Institute of Technology), Karandeep Singh (University of Michigan), and Kristina H. Lewis (Wake Forest Baptist Medical Center)
Researchers, health professionals, and a growing wellness-conscious public use technology to monitor health status. Big Data harnessed from this technology have created a foundation for focused research targeting obesity, but at what cost?
Friday, June 3, 2016 | 8:30 AM - 6:00 PM
Speakers: Agnes C. Agunos (Public Health Agency of Canada), Seamus Fanning (University College Dublin), Delia Grace (International Livestock Research Institute), William J. Hall (Wellcome Trust), Francois Malouin (Sherbrooke University), James L. Marsden (Chipotle Mexican Grill), Alan G. Mathew (Purdue University), H. Morgan Scott (Texas A&M University), Stacy E. Sneeringer (USDA), Jaap A. Wagenaar (Utrecht University), and David R. Wolfgang (Pennsylvania State University)
Antibiotics have been used in human and animal medicine for decades. Reducing the use of antibiotics changes the dynamic between the food supply, food safety, and public health. Food safety practices may emerge a catalyst for change.
Thursday, May 26, 2016 | 9:00 AM - 6:00 PM
Featured Speaker: Peter Godfrey-Faussett (UNAIDS)
This event will address the incidence of non-communicable diseases among people living with HIV, describe morbidity and mortality, and explore interactions among HIV, antiretroviral drugs and behavioral factors influencing development and treatment.
Wednesday, May 18, 2016 | 5:45 PM - 7:00 PM
Moderator: Claudia Wallis (Scientific American Mind)
Panelists: Jeremy Waletzky (The George Washington University), Nora D. Volkow (NIH), Cheryl Healton (College of Global Public Health, New York University), and Honorable Gregory P. Canova, JD
1.3 million adolescents in the US have substance use disorder and marijuana use among teens now exceeds cigarette smoking. Join us for a public panel discussion on how neuroscience intersects with policy to improve lives of teens with addiction.
May 18 - 20, 2016
Keynote Speakers: Nora D. Volkow (National Institute on Drug Abuse, U.S. National Institutes of Health), George F. Koob (National Institute on Alcohol Abuse and Alcoholism, U.S. National Institutes of Health), and The Honorable Patrick J. Kennedy (Former United States Representative, Rhode Island; Co-Founder, One Mind; and Founder, Kennedy Forum)
Discover from leading experts, including NIAAA and NIDA directors, the latest on neurobiology of addiction; susceptibility of the teen brain; new treatment strategies; and social, economic, political, and legislative aspects of this disease.
Keynote Speakers: Jo Handelsman (White House Office of Science and Technology Policy), W. Ian Lipkin (Columbia University), Curtis Huttenhower (Harvard T.H. Chan School of Public Health), and Coby Schal (North Carolina State University)
This eBriefing reviews work to map the urban metagenome to probe the microbial communities in the buildings and subways, soil and sewers in our cities.
Organizers: David Evans (Ohio State University), Refaat Hegazi (Abbott Nutrition Health Institute), Gerard Mullin (Johns Hopkins Medicine), Dennis H. Sullivan (University of Arkansas for the Medical Sciences), Kathy West (Abbott Nutrition Health Institute), Amy R. Beaudreault (The Sackler Institute for Nutrition Science), and Julie Shlisky (The Sackler Institute for Nutrition Science)
This eBriefing reviews interventions for disease-related muscle mass loss.
Edited by Annals of the New York Academy of Sciences
This Annals issue discusses emerging nutrition research on the prevention and management of dementia in aging populations.
Organizers: Alison Bateman-House (NYU School of Medicine), Melanie Brickman Stynes (The New York Academy of Sciences), Arthur Caplan (NYU School of Medicine), Brooke Grindlinger (The New York Academy of Sciences), and Erick Tatro (The New York Academy of Sciences)
This eBriefing explores pre-approval access to investigational medicines, the prospective benefits of which may outweigh the potential risks for critically ill patients.